dual GLP-1R/CCK-2R agonists (Jiangsu Normal University/Jiangnan University/Tumor Hospital of Guangxi Medical University)

N/A

Report date: 2025/03/19 09:03:32
NME

Base Information

Drug Namedual GLP-1R/CCK-2R agonists (Jiangsu Normal University/Jiangnan University/Tumor Hospital of Guangxi Medical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsCholecystokinin B receptor agonists
TargetsCholecystokinin B receptorGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Normal University
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Normal UniversityGuangxi Medical University Cancer CenterJiangnan University
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A